CD4 Cell Count (CD4) Decreases at 24 Weeks despite Adequate Virologic Suppression after Initiating Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI)-based Antiretroviral Therapy (ART) often Improves by 48 Weeks without a Change to Second-line ART